AU2001296014A1 - Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue - Google Patents

Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue

Info

Publication number
AU2001296014A1
AU2001296014A1 AU2001296014A AU9601401A AU2001296014A1 AU 2001296014 A1 AU2001296014 A1 AU 2001296014A1 AU 2001296014 A AU2001296014 A AU 2001296014A AU 9601401 A AU9601401 A AU 9601401A AU 2001296014 A1 AU2001296014 A1 AU 2001296014A1
Authority
AU
Australia
Prior art keywords
recoverying
preventing fatigue
foods
agents
central nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296014A
Inventor
A.Eric Newsholme
Takanobu Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Publication of AU2001296014A1 publication Critical patent/AU2001296014A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001296014A 2000-10-27 2001-10-26 Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue Abandoned AU2001296014A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-329409 2000-10-27
JP2000329409 2000-10-27
JP2001118710 2001-04-17
JP2001-118710 2001-04-17
PCT/JP2001/009439 WO2002034257A1 (en) 2000-10-27 2001-10-26 Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue

Publications (1)

Publication Number Publication Date
AU2001296014A1 true AU2001296014A1 (en) 2002-05-06

Family

ID=26602970

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296014A Abandoned AU2001296014A1 (en) 2000-10-27 2001-10-26 Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue

Country Status (5)

Country Link
US (1) US20040033252A1 (en)
JP (1) JPWO2002034257A1 (en)
AU (1) AU2001296014A1 (en)
CA (1) CA2427030C (en)
WO (1) WO2002034257A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004123564A (en) * 2002-09-30 2004-04-22 Inst Of Physical & Chemical Res Amino acid composition for improving central neural function
KR20120125993A (en) * 2004-07-14 2012-11-19 아지노모토 가부시키가이샤 Inhibitor for the onset and progress of liver cancer to be used in hepatitis c virus-positive human liver cirrhosis patients
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
US7074775B2 (en) 2004-09-14 2006-07-11 Miller Landon C G Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders
JPWO2006080087A1 (en) * 2005-01-31 2008-06-19 山本　隆宣 Antistress substance screening method and antistress substance
US20080114067A1 (en) * 2005-01-31 2008-05-15 Takanobu Yamamoto Composition for Recovery From or Prevention of Central Nervous System Fatigue
US20060210524A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin care composition
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
EP2184062A1 (en) * 2005-06-22 2010-05-12 Ajinomoto Co., Inc. Use of glutamic acid and a nucleic acid as metabotropic glutamate receptor activators
WO2007084752A2 (en) * 2006-01-19 2007-07-26 Sakura Properties, Llc Sports drink concentrate and dehydrated powder
CA2645833C (en) 2006-03-15 2014-12-30 Suntory Limited Compositions containing riboflavin and sesamin-class compounds
CA2689445A1 (en) * 2006-06-01 2007-12-06 Sakura Properties, Llc Fucoidan compositions and methods
JP4163727B2 (en) * 2006-08-31 2008-10-08 本田技研工業株式会社 Oil level detection device for internal combustion engine
TWI397418B (en) 2006-10-10 2013-06-01 Otsuka Pharma Co Ltd Anti-depression drug
CN101626764B (en) 2007-02-28 2012-03-07 株式会社明治 Amino acid composition
US9609884B2 (en) * 2007-03-15 2017-04-04 Suntory Holdings Limited Anti-fatigue agent
CA2703693C (en) 2007-10-31 2016-06-28 Meiji Dairies Corporation Anti-fatigue agent comprising amino acid composition
US20090186098A1 (en) * 2008-01-18 2009-07-23 Jose Briceno Sports drink composition
JP5866138B2 (en) * 2010-10-28 2016-02-17 幸雄 米田 Osteoporosis preventive and / or therapeutic agent, bone resorption inhibitor, osteogenesis promoter and screening method thereof
EP3569070A4 (en) 2017-01-12 2020-10-07 Mitsubishi Gas Chemical Company, Inc. Capsule containing pyrroloquinoline quinone or salt thereof and branched chain amino acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212792B (en) * 1983-11-30 1989-11-30 Egidio Aldo Moja DIETARY SUPPLEMENT AND PRE-PACKED FOOD THAT CONTAINS IT PREPARATION PROCEDURE AND METHOD OF ADMINISTRATION
US5284774A (en) * 1987-02-24 1994-02-08 The United States Of America As Represented By The Secy. Of The Dept. Of Health & Human Resources Antineoplastic, system-L specific amino acid nitrogen mustards
JPH0336833A (en) * 1989-07-04 1991-02-18 Fujitsu Ltd Evaluation function arithmetic circuit
EP0873754B1 (en) * 1996-01-09 2003-07-30 Riken Amino acid compositions
JPH11304793A (en) * 1998-04-27 1999-11-05 Taisho Pharmaceut Co Ltd Method for evaluating mental fatigue refreshing substance
JP2000026290A (en) * 1998-07-07 2000-01-25 Crescendo Corporation:Kk Maintenance of muscular strength with branched chain amino acid

Also Published As

Publication number Publication date
CA2427030A1 (en) 2003-04-25
CA2427030C (en) 2010-06-01
JPWO2002034257A1 (en) 2004-03-04
WO2002034257A1 (en) 2002-05-02
US20040033252A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2001296014A1 (en) Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue
AU5567698A (en) Device for use in the eye
AU6503299A (en) High-beta-conglycinin products and their use
AU2001231048A1 (en) System for trading commodities and the like
AU2001245384A1 (en) Delivery system and method for vehicles and the like
PL339332A1 (en) Assembly member in particular that for use on furniture
ZA991946B (en) Pyrazolopyrimidines and pyrazolotriazines.
AU3548099A (en) Progression elevated gene-3 and uses thereof
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU7597898A (en) Use of isoflavonoids in the treatment or prevention of postpartum depression
AU4900797A (en) Conformationally restricted polyamines and their use as antineoplastic agents
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
AU2841801A (en) Triazolotriazinones and the use thereof
ZA988529B (en) Synergistic herbicidal methods and compositions.
GB2370233B (en) Apparatus for use in behaviour modification and the like
AU2001264852A1 (en) Lactobacillusbeta -glucuronidase and dna encoding the same
AU2413899A (en) Fungicide mixtures based on pyridin carboxamides and benzimidazoles or the precursors thereof
TW360156U (en) Check valve and valve member for the check valve
AU6962698A (en) Transgenomic viruses and the use thereof
ZA99849B (en) Lipid mixtures and their use.
AU5572700A (en) Valve unit and container
AU6494298A (en) Valve arrangement and valve for the same
AU6819598A (en) Anti-counterfeit method and product using the method
AU2001273691A1 (en) Integrated decontamination and characterization system and method
AU2001292368A1 (en) Antiobestic agents and health foods